Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

The levels of caffeine in your blood could affect the amount of body fat you carry, a factor that in turn could determine ...

Comprehensive study exposes critical health risks of obesity, including diabetes, heart disease, and cancer, while offering ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

According to a doctor, when a person suffers from metabolically healthy obesity, most of the fat accumulates in the hips and ...

Obesity has been an ongoing struggle for many consumers, and for years, body mass index (BMI) has been the key metric health ...

NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are ...

The commission recommends a shift away from relying solely on BMI to more accurately define obesity as a disease.

A commission proposed a new definition of obesity focused on how excess fat affects the body, rather than assessing body mass ...

A report from The Lancet Diabetes & Endocrinology Commission has proposed new criteria for defining and diagnosing obesity, ...

Leading health experts challenge traditional BMI measurements and introduce a comprehensive new approach to diagnosing obesity, potentially affecting millions.

Nearly 70% of adults in Indiana are classified as overweight or obese, contributing to a broader health crisis in the United States.